BrainStorm Cell Therapeutics Secures Funding To Reach Clinical Trials For ALS
The new funding includes both a prestigious grant from the Israeli government's Office of the Chief Scientist (OCS) as well as private investment.
"We are very gratified to receive these financial votes of confidence in our breakthrough stem cell technology. The new funding will enable us to complete our pre-clinical studies in ALS and meet our goal of beginning clinical studies in the coming year," said Rami Efrati, CEO of BrainStorm.
The non-equity OCS grant amounts up to $450,000 and marks the third consecutive year in which BrainStorm has been selected as a recipient. The company previously was awarded OCS grants totaling $798,000. BrainStorm's royalty obligations to the OCS are capped at the amount of the grant received from the OCS.
In addition, ACCBT Corporation, a private company investing in biotechnology, has announced that it will implement an additional investment of about $1 million in BrainStorm. ACCBT is under the control of Chaim Lebovits, BrainStorm's President, and has previously invested more than $4 million in the company. The new funding will comprise monthly tranches of $50,000 or more as of August 2009. In return for its investment, ACCBT will receive shares of common stock from the company at a price of $0.12 per share and warrants for $0.29. (Share price as of closing of August 21 is $0.061)
"The promising study results we have seen so far make me confident that the company, with G-D's help, will be able to rapidly progress to a therapy for the unmet medical need of devastating neurodegenerative conditions like ALS," said Mr. Lebovits.
BrainStorm Cell Therapeutics
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Therapeutics, BrainStorm Cell. "BrainStorm Cell Therapeutics Secures Funding To Reach Clinical Trials For ALS." Medical News Today. MediLexicon, Intl., 26 Aug. 2009. Web.
22 Jun. 2017. <http://www.medicalnewstoday.com/releases/161825.php>
Therapeutics, B. (2009, August 26). "BrainStorm Cell Therapeutics Secures Funding To Reach Clinical Trials For ALS." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.